drugset / Trial / NCT00732888
Effect of Calcium on Tasigna Pharmacokinetics (PK) in Healthy Volunteers
RandomizedCrossoverOpen-label
Summary
This research study is being conducted through the University of Pittsburgh Cancer Institute (UPCI). It will evaluate the concentrations of Tasigna®, an oral drug used to treat some types of cancer, in the blood of healthy volunteers when taken with and without Tums Ultra®, a calcium product often used in the treatment of upset stomach and as a calcium supplement.
Timeline
- Start
- 2008-11
- Primary completion
- 2011-08
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nilotinib | Small molecule | 400 mg | Oral |
Indications
No indication recorded.